Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. in 1 story
The narratives 6990.HK currently appears in, with its side and exposure in each.
Bull side
1 story- China Becomes Pharma's Global R&D Engine
6990.HK in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
Its antibody-drug conjugate portfolio makes it a key supplier of sought-after oncology assets to multinational pharma.
Bear side
0 storiesNo bear-side stories for 6990.HK yet.